Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer
Authors
Stevenson, James P.; Redlinger, Maryann; Kluijtmans, Leo A.J.; Sun, Weijing; Algazy, Kenneth; Giantonio, Bruce; Haller, Daniel G.; Hardy, Christine; Whitehead, Alexander S.; O’Dwyer, Peter J.
Publication
Journal of Clinical Oncology, 2001, Vol 19, Issue 20, p4081